ProMis Neurosciences, Inc
2 clinical trials · Sponsor
◉ Watch ProMis Neurosciences, Inc
| Record | Firm | Date |
|---|---|---|
| PMN310 in Patients With Early Alzheimer's Disease (PRECISE-AD) (NCT06750432) | ProMis Neurosciences, Inc | 2024-12-13 |
| A Phase 1a Study of PMN310 In Healthy Volunteers (NCT06105528) | ProMis Neurosciences, Inc | 2023-11-18 |
Track ProMis Neurosciences, Inc automatically
Every clearance here is in the API, with alerts when new ones post.